Ultrasound-stimulated microbubbles have been showing promise in recent years as a non-invasive method of breaking up dangerous blood clots.
Toshiba America Medical Systems Inc. introduced enhancements to its Vantage Titan magnetic resonance (MR) product line.
The American College of Radiology (ACR) commends the House Committee on Ways and Means and the United States Senate Committee on Finance for passing bicameral, bipartisan legislation to replace the flawed sustainable growth rate (SGR) physician payment formula.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
A new study by researchers at the University of California, Los Angeles (UCLA) Fielding School of Public Health and McGill University in Montréal reveals that the United States health care system ranks 22nd out of 27 high-income nations when analyzed for its efficiency of turning dollars spent into extending lives.
The American College of Cardiology (ACC), along with nine specialty and subspecialty societies, released Appropriate Use Criteria (AUC) for tests used in the diagnosis and/or evaluation of stable ischemic heart disease.
CSL Behring announced that Kcentra (Prothrombin Complex Concentrate [Human]) has received U.S. Food and Drug Administration (FDA) approval for an expanded indication — urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA) (warfarin) therapy in adult patients needing an urgent surgery or other invasive procedure.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
BioTelemetry Inc., a wireless medical technology company focused on the delivery of health information, announced that recently published research from an observational study of more than 200,000 patients demonstrates significant in-hospital cost savings in the 12 months following diagnosis using mobile cardiac telemetry (MCT).
Ultrasound will be able to depict blood flow with more detail and accuracy using Toshiba America Medical Systems Inc.’s work-in-progress ultrasound capability, which is the latest advancement to Toshiba’s Aplio 500 ultrasound system.
Double Black Imaging demonstrated its full line of auto-calibrating LED displays at the Radiological Society of North America Annual Meeting (RSNA 2013).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Philips Healthcare introduced the IQon Spectral computed tomography (CT) system at RSNA 2013. It is the world’s first spectral-detector CT system built from the ground up for spectral imaging. It uses color to identify the composition of an image without involving time-consuming protocols.
At RSNA 2013, GE Healthcare introduced the Discovery Interventional Guidance System (IGS) 740, a 510(k)-pending mobile X-ray angiography system with a 41 x 41 cm detector. The system is aimed at interventional radiology market.
Philips unveiled the Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
BioCardia Inc., a cardiovascular regenerative medicine company, announced positive 12-month results for the randomized Transendocardial Autologous Cells (MSC or BMC) in Ischemic Heart Failure Trial (TAC-HFT).
Thomas Jefferson University researchers discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a new understanding of the effects of race on heart disease.
TherOx Inc. released results from the company's multicenter Investigational Device Exemption (IDE) pilot study that showed a 9.6 percent infarct size at 30 days in high-risk patients treated with its next-generation system for Supersaturated Oxygen (SSO2) Therapy. This therapy is intended to provide interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart muscle in heart attack patients. The study results were presented at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
December 18, 2013
